NASDAQ:CTXR
Citius Pharmaceuticals Inc Stock News
$0.660
+0.0114 (+1.76%)
At Close: May 20, 2024
Citius Pharmaceuticals (NASDAQ:CTXR) Shares Gap Up to $1.35
01:52am, Sunday, 19'th Jul 2020
Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $1.52, but opened at $1.35. Citius Pharmaceuticals shares last traded
Citius Pharmaceuticals Brings on Myron S. Czuczman, M.D. as Chief Medical Officer (CMO) and Executive Vice President
12:47pm, Tuesday, 14'th Jul 2020
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that
Citius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
12:16pm, Monday, 13'th Jul 2020Citius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
12:15pm, Monday, 13'th Jul 2020
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that it receive
H.C. Wainwright Thinks Neovasc's Stock is Going to Recover - Markets
10:13am, Thursday, 02'nd Jul 2020
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Neovasc (NVCN – Research Report) today and set a price
Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1%
12:54pm, Tuesday, 30'th Jun 2020
Citius Pharmaceuticals (CTXR) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
01:07pm, Monday, 29'th Jun 2020
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
12:35pm, Monday, 29'th Jun 2020
NEW YORK, June 29, 2020 -- Life Sciences Investor Forum today announced that the presentations from the June 25th conference are now available for on-demand viewing at.
Cel-Sci (CVM) Receives a Buy from H.C. Wainwright - Markets
10:18am, Monday, 29'th Jun 2020
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Cel-Sci (CVM – Research Report),
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novan (NOVN
Citius Pharmaceuticals : CTXR Presentation - Summer 2020 | MarketScreener
06:34pm, Friday, 26'th Jun 2020Citius Pharmaceuticals (CTXR) Investor Presentation - Slideshow
04:42pm, Friday, 26'th Jun 2020
The following slide deck was published by Citius Pharmaceuticals, Inc. in conjunction with this event.
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that
Citius Pharmaceuticals (NASDAQ:CTXR) Rating Lowered to Sell at Zacks Investment Research
01:22am, Wednesday, 24'th Jun 2020
Citius Pharmaceuticals (NASDAQ:CTXR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Monday, Zacks.com reports. According to Zacks,
Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020
12:49pm, Tuesday, 23'rd Jun 2020
NEW YORK, June 23, 2020 -- Life Sciences Investor Forum today announced the agenda for its second quarterly event for public and private companies, investors and industry.
